Literature DB >> 3377435

Brain infarction in sickle cell anemia: magnetic resonance imaging correlates.

S G Pavlakis1, J Bello, I Prohovnik, M Sutton, C Ince, J P Mohr, S Piomelli, S Hilal, D C De Vivo.   

Abstract

Brain infarction is a well-known but poorly understood complication of sickle cell disease. Seventy-three sickle cell disease patients underwent neurological examinations and high-field, heavily T2-weighted axial cranial magnetic resonance image (MRI) scanning. Eighteen of the 73 had a history of stroke, defined as an acute, focal neurological sign lasting longer than 1 hour; in the event of a convulsive onset, an MRI abnormality as a correlate was necessary. Sixteen of the 18 stroke patients demonstrated focal MRI abnormalities consistent with arterial borderzone infarctions. Fifty-five of the 73 patients had no history of stroke. Six of the 55 (11%) had focal MRI abnormalities suggesting previous subclinical stroke. Five of these lesions were in borderzone regions. The distinguishing feature in 21 of the 22 patients with MRI abnormalities was the predilection for lesions in the high cortical convexity, in the general regions of arterial borderzones between the major cerebral arteries and adjacent deep white matter. The pattern of MRI lesions suggests two pathogenetic mechanisms: (1) proximal large-vessel disease with inadequate cerebral perfusion (distal field insufficiency syndrome) and (2) distal small-vessel disease (sludging syndrome).

Entities:  

Mesh:

Year:  1988        PMID: 3377435     DOI: 10.1002/ana.410230204

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  20 in total

Review 1.  Symptomatic intracranial arterial disease: incidence, natural history, diagnosis, and management.

Authors:  Ananth K Vellimana; Andria L Ford; Jin-Moo Lee; Colin P Derdeyn; Gregory J Zipfel
Journal:  Neurosurg Focus       Date:  2011-06       Impact factor: 4.047

2.  Cerebral blood flow mapping using stable xenon-enhanced CT in sickle cell cerebrovascular disease.

Authors:  Y Numaguchi; J S Haller; J R Humbert; A E Robinson; W W Lindstrom; L M Gruenauer; J E Carey
Journal:  Neuroradiology       Date:  1990       Impact factor: 2.804

Review 3.  Stroke in children with sickle cell anaemia: aetiology and treatment.

Authors:  C H Pegelow
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

4.  Large-Vessel Vasculopathy in Children With Sickle Cell Disease: A Magnetic Resonance Imaging Study of Infarct Topography and Focal Atrophy.

Authors:  Kristin P Guilliams; Melanie E Fields; Dustin K Ragan; Yasheng Chen; Cihat Eldeniz; Monica L Hulbert; Michael M Binkley; James N Rhodes; Joshua S Shimony; Robert C McKinstry; Katie D Vo; Hongyu An; Jin-Moo Lee; Andria L Ford
Journal:  Pediatr Neurol       Date:  2016-12-07       Impact factor: 3.372

Review 5.  Neuropsychological aspects of pediatric sickle cell disease.

Authors:  M C Kral; R T Brown; G W Hynd
Journal:  Neuropsychol Rev       Date:  2001-12       Impact factor: 7.444

6.  Subcortical cerebral infarctions in sickle cell trait.

Authors:  M G Reyes
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-04       Impact factor: 10.154

7.  Working Memory in Children With Neurocognitive Effects From Sickle Cell Disease: Contributions of the Central Executive and Processing Speed.

Authors:  Kelsey E Smith; Jeffrey Schatz
Journal:  Dev Neuropsychol       Date:  2016-10-19       Impact factor: 2.253

8.  Stroke in Children with Sickle Cell Disease.

Authors:  Fenella J. Kirkham; Michael R. DeBaun
Journal:  Curr Treat Options Neurol       Date:  2004-09       Impact factor: 3.598

9.  Investigation of stroke in sickle cell disease by 1H nuclear magnetic resonance spectroscopy.

Authors:  Z Wang; A R Bogdan; R A Zimmerman; D A Gusnard; J S Leigh; K Ohene-Frempong
Journal:  Neuroradiology       Date:  1992       Impact factor: 2.804

10.  Neurological 'soft' signs may identify children with sickle cell disease who are at risk for stroke.

Authors:  E Mercuri; J C Faundez; I Roberts; S Flora; H Bouza; F Cowan; J Pennock; G Bydder; L Dubowitz
Journal:  Eur J Pediatr       Date:  1995-02       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.